KK Shah HospitalsBOM:544013 44 EBITDA Margin % is 5.85% as of Mar. 2026, which is 55% below its 10-year median of 12.89. GuruFocus rates BOM:544013 with a GF Score™ of 44/100 and a GF Value™ of ₹51.66 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 664 Healthcare Providers & Services companies, KK Shah Hospitals ranks worse than 50.3% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. KK Shah Hospitals's EBITDA for the
six
months ended in Mar. 2026 was ₹2.70 Mil. KK Shah Hospitals's Revenue for the
six
months ended in Mar. 2026 was ₹46.13 Mil. Therefore, KK Shah Hospitals's EBITDA margin for the quarter that ended in Mar. 2026 was 5.85%.
KK Shah Hospitals (BOM:544013) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
KK Shah Hospitals EBITDA Margin % Related Terms
KK Shah Hospitals EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for KK Shah Hospitals's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544013 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, KK Shah Hospitals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KK Shah Hospitals EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KK Shah Hospitals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where KK Shah Hospitals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KK Shah Hospitals (BOM:544013) has a EBITDA Margin % of 5.85% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on KK Shah Hospitals and its competitors. This is 55% below median its historical median of 12.89. Over the past decade, KK Shah Hospitals' EBITDA Margin % has ranged from 7.63 to 18.37. According to the industry distribution chart, KK Shah Hospitals ranks #334 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 50.3%.
Is KK Shah Hospitals' EBITDA Margin % too high?
KK Shah Hospitals' current EBITDA Margin % of 5.85% is 55% below median its 10-year median of 12.89. Over the past 10 years, this metric has ranged from a low of 7.63 to a high of 18.37. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. KK Shah Hospitals' value of 5.85% is 42.7% below this industry median. Based on the distribution chart, KK Shah Hospitals ranks #334 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, KK Shah Hospitals has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does KK Shah Hospitals' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, KK Shah Hospitals ranks #334 out of 664 companies for EBITDA Margin %. This places KK Shah Hospitals in the lower half of its industry. The industry median EBITDA Margin % is 10.21. KK Shah Hospitals' value of 5.85% is 42.7% below this benchmark. Historically, KK Shah Hospitals' own EBITDA Margin % has ranged from 7.63 to 18.37 over the past decade. While the company's 10-year median is 12.89 vs. the industry median of 10.21, KK Shah Hospitals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KK Shah Hospitals's current EBITDA Margin % of 5.85% is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on KK Shah Hospitals and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KK Shah Hospitals's current EBITDA Margin % is 5.85%, which is 55% below median its own 10-year median of 12.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KK Shah Hospitals stock overvalued right now?
Based on GuruFocus' analysis, KK Shah Hospitals (BOM:544013) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹51.66, compared to a current price of ₹40.00 — trading 22.6% below its estimated fair value. The current EBITDA Margin % is 5.85%, which is 55% below median its 10-year median of 12.89 and 42.7% below the Healthcare Providers & Services industry median of 10.21. KK Shah Hospitals' overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For KK Shah Hospitals (BOM:544013), the current EBITDA Margin % is 5.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KK Shah Hospitals (BOM:544013) Overvalued in 2026?
Based on GuruFocus' analysis, KK Shah Hospitals stock appears to be undervalued.
The current stock price of ₹40.00 is trading 22.6% below its estimated GF Value™ of ₹51.66.
GuruFocus considers KK Shah Hospitals to be Modestly Undervalued.
Key valuation signals for BOM:544013:
EBITDA Margin %: 5.85% (55% below median its 10-year median of 12.89)
GF Value™: ₹51.66 vs. price of ₹40.00 (22.6% below fair value)
Industry Position: 42.7% below the Healthcare Providers & Services median (#334 of 664)
No single metric tells the full story. See the BOM:544013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KK Shah Hospitals Ltd is a company providing healthcare facilities for in-patient treatment, their hospital is also equipped with diagnostic devices such as CT scan, DEXA scan, BMD, sonography, and X-Ray machines. The company is engaged in providing healthcare services which constitutes a single business segment.
44GF Score
Get the complete analysis for BOM:544013
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544013 has been successfully added to your 